Skip to content
10-Q

Quarterly Report

Bio Essence Corp BIOE

0001213900-25-076353

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 38.01M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 $141.73K
Long Term Debt Q2 2025 · Jun 30, 2025 $58.12K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$3.11M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$3.17M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$2.97M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.07M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.8M
Total Liabilities Q2 2025 · Jun 30, 2025 $3.23M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.25M
Current Assets Q2 2025 · Jun 30, 2025 $112.48K
Current Assets Q2 2025 · Dec 31, 2024 $280.69K
Total Assets Q2 2025 · Jun 30, 2025 $112.69K
Total Assets Q2 2025 · Dec 31, 2024 $281.02K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Sga Expense Q2 2025 · Jun 30, 2025 $107.42K
Sga Expense Q2 2025 · Jun 30, 2025 $303.16K
Net Income Q2 2025 · Jun 30, 2025 $59.86K
Net Income Q2 2025 · Jun 30, 2025 −$145.89K
Net Income Q2 2025 · Mar 31, 2025 −$205.75K
Operating Income Q2 2025 · Jun 30, 2025 $61.22K
Operating Income Q2 2025 · Jun 30, 2025 −$143.87K
Gross Profit Q2 2025 · Jun 30, 2025 $168.64K
Gross Profit Q2 2025 · Jun 30, 2025 $189.23K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $90.48K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $92.08K
Revenue Q2 2025 · Jun 30, 2025 $259.12K
Revenue Q2 2025 · Jun 30, 2025 $281.31K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.37K